Al-Haggar Mohammad
Mohammad Al-Haggar, Pediatrics Department, Genetics Unit, Mansoura University Children's Hospital (MUCH), 35516 Mansoura, Egypt.
World J Nephrol. 2013 Nov 6;2(4):94-102. doi: 10.5527/wjn.v2.i4.94.
Cystinosis is an autosomal recessive lysosomal storage disease with an unclear enzymatic defect causing lysosomal cystine accumulation with no corresponding elevation of plasma cystine levels leading to multisystemic dysfunction. The systemic manifestations include a proximal renal tubular defect (Fanconi-like), endocrinal disturbances, eye involvements, with corneal, conjunctival and retinal depositions, and neurological manifestations in the form of brain and muscle dysfunction. Most of the long-term ill effects of cystinosis are observed particularly in patients with long survival as a result of a renal transplant. Its responsible CTNS gene that encodes the lysosomal cystine carrier protein (cystinosin) has been mapped on the short arm of chromosome 17 (Ch17 p13). There are three clinical forms based on the onset of main symptoms: nephropathic infantile form, nephropathic juvenile form and non-nephropathic adult form with predominant ocular manifestations. Avoidance of eye damage from sun exposure, use of cystine chelators (cysteamine) and finally renal transplantation are the main treatment lines. Pre-implantation genetic diagnosis for carrier parents is pivotal in the prevention of recurrence.
胱氨酸贮积症是一种常染色体隐性溶酶体贮积病,酶缺陷不明,导致溶酶体胱氨酸蓄积,而血浆胱氨酸水平无相应升高,进而引发多系统功能障碍。全身表现包括近端肾小管缺陷(类范科尼综合征)、内分泌紊乱、眼部受累,出现角膜、结膜和视网膜沉积,以及以脑和肌肉功能障碍形式表现的神经学症状。胱氨酸贮积症的大多数长期不良影响尤其见于因肾移植而长期存活的患者。其致病基因CTNS编码溶酶体胱氨酸载体蛋白(胱氨酸转运体),已定位在17号染色体短臂(Ch17 p13)上。根据主要症状的发病情况有三种临床类型:肾病型婴儿型、肾病型青少年型和以眼部表现为主的非肾病型成人型。避免阳光照射造成眼损伤、使用胱氨酸螯合剂(半胱胺)以及最终进行肾移植是主要治疗方法。对携带致病基因的父母进行植入前基因诊断对预防复发至关重要。